Patent · US Active

Production of virus-receptive pluripotent stem cell (PSC)-derived hepatocytes

US10093903B2 · kind B2 · utility

2Cited by
1References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 19, 2016
Grant dateOct 9, 2018
Priority date
Expiry dateOct 19, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/02
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present disclosure provides methods for maturing hepatocytes comprising culturing with cyclic adenosine monophosphate and a Janus kinase inhibitor. There is also provided a method for screening inhibitors of hepatitis B virus infection and/or replication.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.